Second-line chemotherapy in epithelial ovarian carcinoma: platinum again? Taxanes? How to choose?
Guastalla
J P
JP
Department of Medical Oncology, Centre Léon-Bérard, Lyon, France.
D004351:Drug Resistance; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000627:therapeutic use*; D010166:Palliative Care / Q000379:methods*; D017671:Platinum Compounds / Q000627:therapeutic use*
D017671:Platinum Compounds; D017239:Paclitaxel